Canopy growth reports fourth quarter and fiscal year 2024 financial results; q4 fy2024 net revenue increased 7% year-over-year, or 16% excluding divested businesses

Storz & bickel® delivered its best q4 revenue quarter, with net revenue increasing 43% as compared to q4 2023 canada medical cannabis net revenue increased 16% in q4 fy2024 and 10% in fy2024 year-over-year            canada cannabis cost of goods sold decreased by 54% in fy2024 versus fy2023 following recent balance sheet actions, the company has no material debt obligation due until march 2026 1 smiths falls, on , may 30, 2024 /prnewswire/ - canopy growth corporation ("canopy", "canopy growth" or the "company") (tsx: weed) (nasdaq: cgc), a world-leading cannabis company dedicated to unleashing the power of cannabis, today announced its financial results for the fourth quarter and fiscal year ended march 31, 2024 and the filing of an annual report on form 10-k, including the audited consolidated financial statements for the fiscal year ended march 31, 2024 and the unqualified report thereon of the company's independent registered public accounting firm.  all financial information in this press release is reported in canadian dollars, unless otherwise indicated.
CGC Ratings Summary
CGC Quant Ranking